Cargando…

Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants

Detalles Bibliográficos
Autores principales:	Aronis, Konstantinos N., Hylek, Elaine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Contemporary Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850242/ https://www.ncbi.nlm.nih.gov/pubmed/29374049 http://dx.doi.org/10.1161/JAHA.117.007338

Ejemplares similares

An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
por: Cove, Christina L., et al.
Publicado: (2013)

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
por: Di Biase, Luigi
Publicado: (2016)

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
por: Chen, Ashley, et al.
Publicado: (2020)

Use of Direct Oral Anticoagulants Among Patients Undergoing Cardioversion: The Importance of Timing Before Cardioversion
por: Warden, Bruce A., et al.
Publicado: (2018)

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
por: Cao, Lin, et al.
Publicado: (2015)

Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants
por: Fauchier, Laurent, et al.
Publicado: (2013)

Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers
por: Bona, Martina, et al.
Publicado: (2021)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
por: Heng, Cai, et al.
Publicado: (2020)

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
por: Testa, Luca, et al.
Publicado: (2019)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
por: Mujer, Mark Terence P., et al.
Publicado: (2020)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
por: Steiner, Thorsten, et al.
Publicado: (2018)

Non-Vitamin K Oral Anticoagulants in Adults with Congenital Heart Disease: A Systematic Review
por: Stalikas, Nikolaos, et al.
Publicado: (2020)

Cost Analysis of a Managed Care Decentralized Outpatient Pharmacy Anticoagulation Service
por: Anderson, Robert
Publicado: (2004)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
por: Dincq, Anne-Sophie, et al.
Publicado: (2014)

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
por: Diener, Hans-Christoph, et al.
Publicado: (2016)

Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020)

Highly Sensitive Cardiac Troponins: The Evidence Behind Sex‐Specific Cutoffs
por: Bhatia, Prerana M., et al.
Publicado: (2020)

Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)

Evidence That a Subset of Aneurysms Less Than 7 mm Warrant Treatment
por: Zanaty, Mario, et al.
Publicado: (2016)

Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and Controversies
por: Tajti, Peter, et al.
Publicado: (2018)

High‐Sensitivity Troponin Assays: Evidence, Indications, and Reasonable Use
por: Sherwood, Matthew W., et al.
Publicado: (2014)

Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
por: Goldstein, Patrick, et al.
Publicado: (2013)

Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants
por: Patel, Raj
Publicado: (2016)

Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
por: Bisson, Arnaud, et al.
Publicado: (2017)

Assessment of non‐vitamin K antagonist oral anticoagulants for the management of left ventricular thrombus
por: Li, Shunhui, et al.
Publicado: (2021)

Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
por: Lee, Ki Hong, et al.
Publicado: (2023)

Transforming graduate nursing education during an era of social distancing: Tools from the field()
por: de Tantillo, Lila, et al.
Publicado: (2020)

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
por: Cullell, Natalia, et al.
Publicado: (2018)

The use of non‐vitamin K oral anticoagulants in dialysis patients—A systematic review
por: Chandrasegaram, Agitha, et al.
Publicado: (2022)

Updates for Cardio‐Kidney Protective Effects by Angiotensin Receptor‐Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection
por: Tsukamoto, Shunichiro, et al.
Publicado: (2023)

Therapeutic Management of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva: Current Evidence, Proposed Approach, and the Unknowing
por: Bigler, Marius Reto, et al.
Publicado: (2022)

Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
por: Bang, Oh Young, et al.
Publicado: (2016)

Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
por: Anghel, Larisa, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
por: Fanaroff, Alexander C, et al.
Publicado: (2022)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
por: Malhotra, Konark, et al.
Publicado: (2017)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
por: Malagù, Michele, et al.
Publicado: (2023)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Non-vitamin K oral anticoagulant use in the elderly: a prospective real-world study – data from the REGIstry of patients on Non-vitamin K oral Anticoagulants (REGINA)
por: Monelli, Mauro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n0uf9k87se9c1n60fo82cpsvpr